Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke.
Author S Simon Fandler-HöflerRudolf E StauberMarkus KneihslGerit WünschMelanie HaideggerBirgit PoltrumAlexander PichlerHannes DeutschmannChristian EnzingerPeter FickertThomas GattringerPublished in: Therapeutic advances in neurological disorders (2021)
Clinically inapparent liver fibrosis (based on simple clinical and laboratory parameters) represents an independent risk factor for unfavorable outcomes, including mortality, at three months after stroke thrombectomy. Elevated liver fibrosis indices warrant further hepatological work-up and thorough screening for atrial fibrillation in stroke patients.
Keyphrases
- liver fibrosis
- atrial fibrillation
- heart failure
- oral anticoagulants
- catheter ablation
- left atrial
- cardiovascular events
- left atrial appendage
- risk factors
- percutaneous coronary intervention
- type diabetes
- cardiovascular disease
- venous thromboembolism
- brain injury
- coronary artery disease
- blood brain barrier
- mitral valve